Your browser doesn't support javascript.
loading
Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD.
Atschekzei, Faranaz; Fedchenko, Mykola; Elsayed, Abdulwahab; Dubrowinskaja, Natalia; Graalmann, Theresa; Ringshausen, Felix C; Witte, Torsten; Sogkas, Georgios.
Affiliation
  • Atschekzei F; Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
  • Fedchenko M; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.
  • Elsayed A; Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Dubrowinskaja N; Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
  • Graalmann T; Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.
  • Ringshausen FC; Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
  • Witte T; Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
  • Sogkas G; Junior Research Group for Translational Immunology, TWINCORE, Center for Infection Research and the Hannover Medical School, Hannover, Germany.
RMD Open ; 9(4)2023 Dec 07.
Article in En | MEDLINE | ID: mdl-38088248
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sjogren's Syndrome / Prolidase Deficiency Limits: Adult / Child / Female / Humans Language: En Journal: RMD Open Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sjogren's Syndrome / Prolidase Deficiency Limits: Adult / Child / Female / Humans Language: En Journal: RMD Open Year: 2023 Type: Article Affiliation country: Germany